My theory which I posted a month ago (15th of April) was that the cap raising prospectus read like a "what we have to do to be bought out" document. Interestingly one of TIS's competitors (makers of Dermagraft) just got bought out literally hours before it was due to go public. The following articles give some information about Dermagraft and the takeover of its parent company Advanced BioHealing.
Article - Dermagraft and Apligraf info - also note Dermagraft's 2010 list price in the US.
http://www.genengnews.com/keywordsandtools/print/1/22133/
Article - Pre-IPO info
http://seekingalpha.com/article/270018-ipo-preview-advanced-biohealing?source=feed
Article - Takeover details
http://www.businessweek.com/news/2011-05-18/shire-hits-sweet-spot-with-750-million-u-s-acquisition.html
Article - More Takeover details
http://www.minyanville.com/businessmarkets/articles/shire-advanced-biohealing-biotech-investing-biotech/5/18/2011/id/34633
- Forums
- ASX - By Stock
- TIS
- a competitor just got taken over
a competitor just got taken over
Featured News
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online